L & S Advisors’s GoodRx Holdings GDRX Stock Holding History

L & S Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,000	Closed	-$205K	–	314
2021 Q3	$205K	Buy	+5,000	New	+$181K	0.02%	322
2021 Q1	–	Sell	-5,000	Closed	-$202K	–	365
2020 Q4	$202K	Sell	5,000 -21,817	-81%	-$1M	0.02%	325
2020 Q3	$1.49M	Buy	+26,817	New	+$1.42M	0.21%	156

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Abdiel Capital Advisors New York $52M AUM 13.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

L & S Advisors's GDRX Position: Q4 2021 in Review

L & S Advisors sold out of GoodRx Holdings (GDRX) in Q4 2021, closing a stake of 5,000 shares — an estimated $205K sold.

L & S Advisors first reported a position in GDRX in Q3 2020 and held it in 3 quarters. The position peaked at $1.49M in Q3 2020. 216 funds tracked by Wall St. Rank hold GDRX as of Q4 2021.

L & S Advisors reported no remaining GoodRx Holdings position as of Q4 2021 after selling out during the quarter.
L & S Advisors sold 5,000 GoodRx Holdings shares in Q4 2021, an estimated $205K.
L & S Advisors first reported a position in GoodRx Holdings in Q3 2020 and held it in 3 quarters.
L & S Advisors's GoodRx Holdings position peaked at $1.49M in Q3 2020.
216 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2021.

Based on L & S Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.